Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
OtherIndices

Subject Index to Volume 36, 2023

The Journal of the American Board of Family Medicine November 2023, 36 (6) 1105-1115;
  • Article
  • References
  • Info & Metrics
  • PDF
Loading
  • Abortion, provision, and core values of family medicine, 36(4):583–590

  • Academic detailing, panel management, and colorectal cancer stool-DNA testing, 36(6):933–941

  • Access to health care, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Access to primary care, integrating harm reduction into medical care, 36(3):449–461

  • Accountable care organization, deployment of digital advance care planning platform, 36(6):966–975

  • Accreditation Council for Graduate Medical Education (ACGME)

  •  implementing competency-based ABFM board eligibility, 36(4):703–707

  •  new family and medical leave policy, 36(1):190–192

  • Acute pain, initial care for low back pain, 36(6):986–995

  • Adolescent

  •  failure to participate in sports, 36(6):1033–1037

  •  integrating a vaping assessment tool into the EHR, 36(3):405–413

  • Advance care planning, deployment of digital platform, 36(6):966–975

  • Advanced practice providers, in family medicine departments, 36(6):1058–1061

  • Adverse childhood experiences (ACEs), parental, and child weight, 36(1):39–50

  • Adverse drug event, ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163

  • Aging

  •  deployment of digital advance care planning platform, 36(6):966–975

  •  peripheral neuropathy and reduced life expectancy, 36(3):431–438

  • Altruism, an exploration of professionalism in practice, 36(3):515–519

  • American Board of Family Medicine (ABFM)

  •  implementing competency-based ABFM board eligibility, 36(4):703–707

  •  Introducing the Inaugural ABFM Research and Editing Fellow, 36(4):530

  • Angioedema, of the small bowel, ACE inhibitor-induced, 36(1):160–163

  • Angiotensin-converting enzyme (ACE) inhibitors, and angioedema of the small bowel, 36(1):160–163

  • Antibacterial drug resistance, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Antidepressants, tapering routine, 36(1):145–151

  • Antimicrobial stewardship, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Anxiety disorders, antidepressant tapering routine, 36(1):145–151

  • Arizona, ICAN Discussion Aid and patient burdens, 36(2):277–288

  • Artificial intelligence (AI), applications in primary care, 36(2):210–220

  • Asthma

  •  diagnosis documentation, childhood wheeze and, 36(6):1038–1042

  •  quality of care for Latinx children with, 36(4):616–625

  •  reducing carbon footprint when prescribing inhalers, 36(2):356–359

  •  what patients call their inhalers, 36(4):650–661

  • Athletes, failure of preparticipation sports physicals, 36(6):1033–1037

  • Behavioral medicine

  •  clinical model of suffering, 36(2):344–355

  •  ICAN Discussion Aid and patient burdens, 36(2):277–288

  • Behavioral science, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Bipolar disorder, antidepressant tapering routine, 36(1):145–151

  • Bisphosphonates, versus denosumab, for reducing fractures, 36(1):175–185

  • Body composition

  •  models for delivering weight management, 36(4):603–615

  •  weight loss management in primary care, 36(1):51–65

  • Body mass index, parental ACEs and child weight, 36(1):39–50

  • Breast cancer

  •  lung cancer screening among mammography patients, 36(4):557–564

  •  patient confidence in screening mammography, 36(6):942–951

  •  women at high risk for, 36(6):1029–1032

  • Breast density, patient confidence in screening mammography, 36(6):942–951

  • Breastfeeding

  •  detection and management of perinatal depression, 36(6):1071–1086

  •  infant and maternal vitamin D supplementation, 36(1):95–104

  • Buprenorphine

  •  end of the “X-waiver” program, 36(5):867–872

  •  follow-up care, nurse standing orders for, 36(5):723–730

  • Burden of illness, ICAN Discussion Aid and patient burdens, 36(2):277–288

  • Canada

  •  AI applications in primary care, 36(2):210–220

  •  continuity, payment, and terms in Canadian health, 36(1):130–141

  •  providers and staff perceptions of AI, 36(2):221–228

  • Cancer, survivorship guidelines, use of, 36(5):789–802

  • Cancer screening

  •  data challenges for rural colorectal cancer screening, 36(1):118–129

  •  effects of multi-component intervention, 36(6):933–941

  •  experiences with lung cancer screening implementation, 36(6):952–965

  •  patient confidence in screening mammography, 36(6):942–951

  •  women at high risk for breast cancer, 36(6):1029–1032

  • Cancer survivors, use of cancer survivorship guidelines, 36(5):789–802

  • Cannabinoids, integrating a vaping assessment tool into the EHR, 36(3):405–413

  • Cannabis

  •  physician perspectives on medical cannabis, 36(4):670–681

  •  use for pain versus use for other reasons, 36(6):996–1007

  • Carbon dioxide, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Carbon footprint, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Cardiology

  •  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476

  •  clinical decision support and medication prescribing, 36(5):777–788

  • Cardiovascular diseases

  •  clinical decision support and medication prescribing, 36(5):777–788

  •  risk reduction of quality improvement initiative, 36(3):462–476

  • Career choice

  •  practice type and scope of care, 36(1):79–87

  •  reflections in family medicine, 36(5):873–875

  • Caregiver burden, ICAN Discussion Aid and patient burdens, 36(2):277–288

  • Caregivers

  •  children's special health care needs during COVID-19, 36(5):731–738

  •  home health workers' interactions for heart failure, 36(2):369–375

  •  patient and patient caregiver perspectives on social screening, 36(1):66–78

  • Case report, ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163

  • Catastrophization, high pain catastrophizing and opioid-related awareness, 36(2):267–276

  • Cesarean section, family physicians providing, 36(4):565–573

  • Chemoprophylaxis, women at high risk for breast cancer, 36(6):1029–1032

  • Chief executive officers, increasing primary care physicians in top leadership roles, 36(4):687–689

  • Child health

  •  childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042

  •  children's special health care needs during COVID-19, 36(5):731–738

  •  quality of care for Latinx children with asthma, 36(4):616–625

  • Childhood obesity, parental ACEs and, 36(1):39–50

  • Chronic disease

  •  adherence to diabetes medications during COVID-19, 36(2):289–302

  •  clinical model of suffering, 36(2):344–355

  •  continuity of care and hospitalization, 36(2):303–312

  •  goal-oriented prevention, 36(2):333–338

  •  health insurance and chronic health conditions, 36(5):839–850

  •  home health workers' interactions for heart failure, 36(2):369–375

  •  ICAN Discussion Aid and patient burdens, 36(2):277–288

  •  impact of COVID-19 on care coordination patients, 36(4):662–669

  •  obesity and patient-physician relationship, 36(2):325–332

  •  tool to enhance functional status assessment, 36(1):4–14

  • Chronic obstructive pulmonary disease, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Chronic pain

  •  cannabis use for pain versus use for other reasons, 36(6):996–1007

  •  urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  • Climate change, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Clinical competence, role of practical wisdom in primary care, 36(4):531–536

  • Clinical decision-making

  •  goal-oriented prevention, 36(2):333–338

  •  role of practical wisdom in primary care, 36(4):531–536

  • Clinical decision rules, patient-reporting system for predicting influenza, 36(5):766–776

  • Clinical decision support systems, clinical decision support and medication prescribing, 36(5):777–788

  • Clinical medicine

  •  clinical model of suffering, 36(2):344–355

  •  goal-oriented prevention, 36(2):333–338

  •  ICAN Discussion Aid and patient burdens, 36(2):277–288

  •  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  •  patient and patient caregiver perspectives on social screening, 36(1):66–78

  • Clinical pharmacy service, home-based primary care for older adults with limited mobility, 36(4):550–556

  • Clinical trials

  •  clinical decision support and medication prescribing, 36(5):777–788

  •  FDA initiative for diversity in clinical trials, 36(2):366–368

  •  medical-legal partnership randomized clinical trials, 36(3):414–424

  • Coccidioides, extra-articular coccidioidomycosis in the knee, 36(2):376–379

  • Coccidioidomycosis, extra-articular coccidioidomycosis in the knee, 36(2):376–379

  • Cohort studies, use of patient-reporting system for predicting influenza, 36(5):766–776

  • Collaborative learning, implementing whole person primary care, 36(4):542–549

  • Colonoscopy

  •  data challenges for rural colorectal cancer screening, 36(1):118–129

  •  severe harm due to screening colonoscopy, 36(3):493–500

  • Colorado, weight loss management in primary care, 36(1):51–65

  • Colorectal cancer

  •  data challenges for rural screening, 36(1):118–129

  •  effects of multi-component intervention on screening, 36(6):933–941

  •  guidelines for germline testing of, 36(2):360–365

  •  severe harm due to screening colonoscopy, 36(3):493–500

  • Commentaries

  •  The ACGME's New Paid Family and Medical Leave Policy: Just the Beginning, 36(1):190–192

  •  Delivering High-Quality Primary Care Requires Work That Is Worthwhile for Medical Assistants, 36(1):193–199

  •  Diversifying the Federal Family Medicine Physician Workforce, 36(1):200–202

  •  The End of the X-waiver: Excitement, Apprehension, and Opportunity, 36(5):867–872

  •  Ensuring Community Is at the Table in Family and Community Medicine Research: Highlighting Dr. Kevin Grumbach’s Speech as Recipient of the 2022 NAPCRG Wood Award, 36(6):1068–1070

  •  The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials, 36(2):366–368

  •  Few Primary Care Physicians Lead Hospitals, Despite Their Immense Value: Systems Change and Delivery System Evolution Can Reverse This Trend, 36(4):687–689

  •  Fraud, Access, and the Future of Telemedicine, 36(5):864–866

  •  Medicare Advantage: Growth Amidst Mounting Scrutiny, 36(6):1062–1064

  •  Pharmacy Benefit Managers in the Eye of the Storm: Growing Multipartite Scrutiny, 36(6):1065–1067

  •  A Response to the Decline in Family Practitioners Performing Obstetric Care, 36(4):690–691

  •  Supporting the Capture of Social Needs Through Natural Language Processing, 36(3):513–514

  • Communication

  •  clinical model of suffering, 36(2):344–355

  •  ICAN Discussion Aid and patient burdens, 36(2):277–288

  • Community-based research

  •  children's special health care needs during COVID-19, 36(5):731–738

  •  delays in COVID-19-related hospitalization, 36(5):832–838

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Community health centers

  •  clinical decision support and medication prescribing, 36(5):777–788

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  health insurance and chronic health conditions, 36(5):839–850

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Community medicine

  •  appointment cancellations and hospital utilization, 36(2):339–343

  •  failure to participate in sports, 36(6):1033–1037

  •  nurse standing orders for buprenorphine follow-up care, 36(5):723–730

  • Community resources, social isolation and a resource referral platform, 36(5):803–816

  • Competency-based education, implementing competency-based ABFM board eligibility, 36(4):703–707

  • Comprehensive health care, clinical model of suffering, 36(2):344–355

  • Connective tissue, extra-articular coccidioidomycosis in the knee, 36(2):376–379

  • Continuing medical education, standards for dermoscopy education in primary care, 36(1):25–38

  • Continuity of patient care

  •  appointment cancellations and hospital utilization, 36(2):339–343

  •  clinical model of suffering, 36(2):344–355

  •  continuity, payment, and terms in Canadian health, 36(1):130–141

  •  continuity of care and hospitalization, 36(2):303–312

  •  physician continuity and cost of care, 36(6):976–985

  • Correspondence

  •  approach to hair loss in hijab-wearing individuals in primary care, 36(1):186–187

  •  developing and validating a novel tool to enhance functional status assessment: the Tennessee Functional Status Questionnaire (TFSQ), 36(6):1094–1095

  •  estimate of severe harms due to screening colonoscopy: a systematic review, 36(6):1092–1093

  •  estimating the cardiovascular disease risk reduction of quality improvement initiative in primary care: findings from EvidenceNOW, 36(6):1087–1090

  •  evaluating the uptake of antiracism training, policies, and practices in departments of family medicine, 36(6):1090–1092

  •  expert consensus statement on proficiency standards for dermoscopy education in primary care, 36(4):695–696

  •  FDA initiative to assure racial and ethnic diversity in clinical trials, 36(6):1095–1096

  •  integrating a systematic, comprehensive e-cigarette and vaping assessment tool into the electronic health record, 36(6):1096–1097

  •  it’s time to retire the term “provider” from JABFM’s pages, 36(3):520–521

  •  keeping score of the scores: additional perspectives on the decline of family medicine ITE scores, 36(5):876–877

  •  local economic inequality and the primary care physician workforce in North Carolina, 36(4):697

  •  prevalence of low-value prostate cancer screening in primary care clinics: a study using the National Ambulatory Medical Care Survey, 36(3):521

  •  programs can improve the diversity workforce in family medicine, 36(4):695–696

  • Cost, of care, physician continuity and, 36(6):976–985

  • COVID-19

  •  acceptance of social needs navigation, 36(2):229–239

  •  ACGME's new family and medical leave policy, 36(1):190–192

  •  adherence to diabetes medications during, 36(2):289–302

  •  appointment cancellations and hospital utilization, 36(2):339–343

  •  burnout and commitment after, 36(1):105–117

  •  children's special health care needs during, 36(5):731–738

  •  colorectal cancer screening outreach during, 36(6):933–941

  •  and community health center care delivery, 36(6):916–926

  •  death, risk of, telephonic follow-up and, 36(1):164–169

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  fraud, access, and future of telemedicine, 36(5):864–866

  •  hospitalization, COVID-19-related, delays in, 36(5):832–838

  •  hospitalization, health care costs following, 36(6):883–891

  •  IBH adaptations during, 36(6):1023–1028

  •  impact of on care coordination patients, 36(4):662–669

  •  impact on family physicians, 36(6):905–915

  •  intimate partner violence and telemedicine usage, 36(5):755–765

  •  Medicaid expansion and practice ownership, 36(6):892–904

  •  mRNA vaccination trends, 36(6):927–932

  •  telehealth and policy implications for equity, 36(5):746–754

  •  vaccination and financial incentives, 36(1):170–174

  •  vaccine, mRNA vaccination trends, 36(6):927–932

  • Craving, virtual music therapy for substance use disorders, 36(6):1043–1049

  • Cross-cultural comparison, FDA initiative for diversity in clinical trials, 36(2):366–368

  • Cross-sectional studies

  •  acceptance of social needs navigation, 36(2):229–239

  •  continuity of care and hospitalization, 36(2):303–312

  •  family physicians providing cesarean sections, 36(4):565–573

  •  high pain catastrophizing and opioid-related awareness, 36(2):267–276

  •  home health workers' interactions for heart failure, 36(2):369–375

  •  non-adherence behaviors and diabetes outcomes, 36(1):15–24

  •  patient confidence in screening mammography, 36(6):942–951

  •  periodontitis among US adults with multimorbidity, 36(2):313–324

  •  physician continuity and cost of care, 36(6):976–985

  • Cultural diversity, FDA initiative for diversity in clinical trials, 36(2):366–368

  • Culturally sensitive research

  •  delays in COVID-19-related hospitalization, 36(5):832–838

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Culture change, increasing primary care physicians in top leadership roles, 36(4):687–689

  • Data set, landscape of pregnancy care in community health centers, 36(4):574–582

  • Decision-making, clinical decision support and medication prescribing, 36(5):777–788

  • Delivery of health care

  •  high-quality care requires worthwhile work, 36(1):193–199

  •  home health workers' interactions for heart failure, 36(2):369–375

  •  impact of COVID-19 on care coordination patients, 36(4):662–669

  •  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  •  patient and patient caregiver perspectives on social screening, 36(1):66–78

  • Delphi method, standards for dermoscopy education in primary care, 36(1):25–38

  • Demography, demographics and engagement in interprofessional collaboration, 36(1):88–94

  • Denosumab, versus bisphosphonates, for reducing fractures, 36(1):175–185

  • Depression

  •  antidepressant tapering routine, 36(1):145–151

  •  perinatal, detection and management in primary care, 36(6):1071–1086

  • Dermoscopy, education, standards for, in primary care, 36(1):25–38

  • Diabetes mellitus

  •  adherence to diabetes medications during COVID-19, 36(2):289–302

  •  non-adherence behaviors and diabetes outcomes, 36(1):15–24

  • Diagnostic imaging, women at high risk for breast cancer, 36(6):1029–1032

  • Dietary supplements, infant and maternal vitamin D supplementation, 36(1):95–104

  • Disability, hearing loss with hospitalization, 36(3):439–448

  • Disease management

  •  ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163

  •  adherence to diabetes medications during COVID-19, 36(2):289–302

  •  clinical model of suffering, 36(2):344–355

  •  goal-oriented prevention, 36(2):333–338

  •  home-based primary care for older adults with limited mobility, 36(4):550–556

  •  use of cancer survivorship guidelines, 36(5):789–802

  •  utilization of MAT for opioid use disorder, 36(2):251–266

  • Disinformation, reflections in family medicine, 36(4):692–694

  • Diversity

  •  diversifying federal family medicine, 36(1):200–202

  •  physician racial diversity in federal sites, 36(1):188–189

  • DNA, colorectal cancer stool-DNA testing, 36(6):933–941

  • Drug costs, pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067

  • Drug prescriptions, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Drug tapering, antidepressant tapering routine, 36(1):145–151

  • Dry powder inhalers, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Early detection of cancer

  •  low-value prostate cancer screening in primary care, 36(1):152–159

  •  lung cancer screening among mammography patients, 36(4):557–564

  •  severe harm due to screening colonoscopy, 36(3):493–500

  • Early medical intervention, virtual Medicare Annual Wellness Visit intervention, 36(3):501–509

  • Editorial Office News and Notes

  •  Introducing the Inaugural ABFM Research and Editing Fellow, 36(4):530

  •  Peer Reviewers for the Journal of the American Board of Family Medicine in 2022, 36(3):386–389

  • Editors' Notes

  •  Family Physicians Can/Should Do: What? Where? And How?, 36(1):1–3

  •  Lingering Impact of COVID-19, Preventive Care Considerations, and US Health System Challenges, 36(6):879–882

  •  Practicing Family Medicine in a Pandemic World: Lessons for Telemedicine, Health Care Delivery, and Mental Health Care, 36(5):709–711

  •  Research Addressing the Ongoing Changes in the Practice of Family Medicine, 36(3):383–385

  •  Research Representing the Changing Landscape of Family Medicine, 36(2):207–209

  •  Thinking and Practicing Thoughtfully and Thoroughly, 36(4):527–529

  • Elderly, Medicare Advantage, growth amidst mounting scrutiny, 36(6):1062–1064

  • Electronic cigarettes, integrating a vaping assessment tool into the EHR, 36(3):405–413

  • Electronic health records

  •  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057

  •  childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042

  •  COVID-19 and community health center care delivery, 36(6):916–926

  •  data challenges for rural colorectal cancer screening, 36(1):118–129

  •  determining patients' social needs in, 36(3):510–512

  •  integrating a vaping assessment tool into, 36(3):405–413

  • Empathy, clinical model of suffering, 36(2):344–355

  • End of life care, clinical model of suffering, 36(2):344–355

  • Entrustable professional services, implementing competency-based ABFM board eligibility, 36(4):703–707

  • Environmental medicine, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Epidemiology

  •  children's special health care needs during COVID-19, 36(5):731–738

  •  patient's characteristics and management of symptom diagnoses, 36(3):477–492

  • Equity

  •  diversifying federal family medicine, 36(1):200–202

  •  physician racial diversity in federal sites, 36(1):188–189

  • Ethnic and racial minorities, race and ethnicity differences in solo practices, 36(2):380–381

  • Evidence-based medicine, role of practical wisdom in primary care, 36(4):531–536

  • Exercise

  •  failure to participate in sports, 36(6):1033–1037

  •  tool to enhance functional status assessment, 36(1):4–14

  • Expert opinion, standards for dermoscopy education in primary care, 36(1):25–38

  • Family health history, women at high risk for breast cancer, 36(6):1029–1032

  • Family leave, ACGME's new family and medical leave policy, 36(1):190–192

  • Family medicine

  •  academic detailing, panel management, and colorectal cancer stool-DNA testing, 36(6):933–941

  •  ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163

  •  AI applications in primary care, 36(2):210–220

  •  appointment cancellations and hospital utilization, 36(2):339–343

  •  clinical model of suffering, 36(2):344–355

  •  core values of, and abortion provision, 36(4):583–590

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  departments, advanced practice providers in, 36(6):1058–1061

  •  end of the “X-waiver” program, 36(5):867–872

  •  family physician early-career compensation, 36(5):851–863

  •  federal, diversifying, 36(1):200–202

  •  high pain catastrophizing and opioid-related awareness, 36(2):267–276

  •  IBH adaptations during COVID-19, 36(6):1023–1028

  •  IBH implementation and training in primary care, 36(6):1008–1019

  •  ICAN Discussion Aid and patient burdens, 36(2):277–288

  •  increasing treatment rates for hepatitis C, 36(4):591–602

  •  landscape of pregnancy care in community health centers, 36(4):574–582

  •  medical-legal partnership randomized clinical trials, 36(3):414–424

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  •  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  •  patient's characteristics and management of symptom diagnoses, 36(3):477–492

  •  physician racial diversity in federal sites, 36(1):188–189

  •  practice type and scope of care, 36(1):79–87

  •  providers and staff perceptions of AI, 36(2):221–228

  •  reducing carbon footprint when prescribing inhalers, 36(2):356–359

  •  weight loss management in primary care, 36(1):51–65

  • Family physicians

  •  advanced practice providers in family medicine departments, 36(6):1058–1061

  •  attending deliveries and providing perinatal care, 36(4):685–686

  •  decline in provision of obstetric care, 36(4):690–691

  •  determining patients' social needs in EHRs, 36(3):510–512

  •  diversifying federal family medicine, 36(1):200–202

  •  early-career compensation, 36(5):851–863

  •  impact of COVID-19 on, 36(6):905–915

  •  providing cesarean sections, 36(4):565–573

  •  race and ethnicity differences in solo practices, 36(2):380–381

  •  racial diversity in federal sites, 36(1):188–189

  • Focus groups

  •  increasing treatment rates for hepatitis C, 36(4):591–602

  •  standards for dermoscopy education in primary care, 36(1):25–38

  • Follow-up care, experiences with lung cancer screening implementation, 36(6):952–965

  • Follow-up studies

  •  burnout and commitment after COVID-19, 36(1):105–117

  •  telephonic follow-up and risk of COVID-19 death, 36(1):164–169

  • Food assistance, food insecurity screening in safety-net clinics, 36(2):240–250

  • Food insecurity, screening, in safety-net clinics, 36(2):240–250

  • Fraud, access, and future of telemedicine, 36(5):864–866

  • Friendship, reflections in family medicine, 36(6):1020–1022

  • Functional performance, tool to enhance functional status assessment, 36(1):4–14

  • Gender differences, demographics and engagement in interprofessional collaboration, 36(1):88–94

  • Gender equity, family physician early-career compensation, 36(5):851–863

  • General practitioners, standards for dermoscopy education in primary care, 36(1):25–38

  • Genetic testing, guidelines for germline testing of colorectal cancer, 36(2):360–365

  • Geriatrics

  •  deployment of digital advance care planning platform, 36(6):966–975

  •  health insurance and chronic health conditions, 36(5):839–850

  •  home-based primary care for older adults with limited mobility, 36(4):550–556

  •  low-value prostate cancer screening in primary care, 36(1):152–159

  •  peripheral neuropathy and reduced life expectancy, 36(3):431–438

  •  tool to enhance functional status assessment, 36(1):4–14

  •  virtual Medicare Annual Wellness Visit intervention, 36(3):501–509

  • Germline mutation, guidelines for germline testing of colorectal cancer, 36(2):360–365

  • Global warming, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Government regulation and oversight, pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067

  • Graduate medical education, ACGME's new family and medical leave policy, 36(1):190–192

  • Greenhouse gases, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Harm reduction, integrating harm reduction into medical care, 36(3):449–461

  • HCV antibodies, increasing treatment rates for hepatitis C, 36(4):591–602

  • Health behavior, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Health care disparities

  •  childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042

  •  community health center social risk screening initiatives, 36(5):817–831

  •  continuity of care and hospitalization, 36(2):303–312

  •  COVID-19 and community health center care delivery, 36(6):916–926

  •  FDA initiative for diversity in clinical trials, 36(2):366–368

  •  health insurance and chronic health conditions, 36(5):839–850

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Health care economics, health care costs following COVID-19 hospitalization, 36(6):883–891

  • Health care financing

  •  Medicare Advantage, growth amidst mounting scrutiny, 36(6):1062–1064

  •  pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067

  • Health care seeking strategies of patients, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Health care surveys, obesity and patient-physician relationship, 36(2):325–332

  • Health communication, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Health equity

  •  clinical decision support and medication prescribing, 36(5):777–788

  •  community health center social risk screening initiatives, 36(5):817–831

  •  deployment of digital advance care planning platform, 36(6):966–975

  •  quality of care for Latinx children with asthma, 36(4):616–625

  •  telehealth and policy implications for equity, 36(5):746–754

  • Health expenditures

  •  health care costs following COVID-19 hospitalization, 36(6):883–891

  •  home-based primary care for older adults with limited mobility, 36(4):550–556

  • Health-harming legal needs, medical-legal partnership randomized clinical trials, 36(3):414–424

  • Health information technology, social isolation and a resource referral platform, 36(5):803–816

  • Health insurance

  •  and chronic health conditions, 36(5):839–850

  •  Medicare Advantage, 36(6):1062–1064

  •  pharmacy benefit managers, 36(6):1065–1067

  • Health literacy

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  •  what patients call their inhalers, 36(4):650–661

  • Health personnel, high-quality care requires worthwhile work, 36(1):193–199

  • Health policy

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  financial incentives and COVID-19 vaccination, 36(1):170–174

  •  pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067

  •  physician perspectives on medical cannabis, 36(4):670–681

  •  telehealth and policy implications for equity, 36(5):746–754

  • Health promotion

  •  goal-oriented prevention, 36(2):333–338

  •  lung cancer screening among mammography patients, 36(4):557–564

  •  tool to enhance functional status assessment, 36(1):4–14

  • Health services

  •  impact of COVID-19 on care coordination patients, 36(4):662–669

  •  pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067

  • Health services accessibility

  •  attending deliveries and providing perinatal care, 36(4):685–686

  •  COVID-19, and community health center care delivery, 36(6):916–926

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  decline in family practitioners performing obstetric care, 36(4):690–691

  •  delays in COVID-19-related hospitalization, 36(5):832–838

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  fraud, access, and future of telemedicine, 36(5):864–866

  •  health insurance and chronic health conditions, 36(5):839–850

  •  landscape of pregnancy care in community health centers, 36(4):574–582

  •  race and ethnicity differences in solo practices, 36(2):380–381

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Hearing loss, with hospitalization, 36(3):439–448

  • Heart failure, home health workers' interactions, 36(2):369–375

  • Hepatitis C, increasing treatment rates for, 36(4):591–602

  • Hispanics

  •  delays in COVID-19-related hospitalization, 36(5):832–838

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Hoax, reflections in family medicine, 36(4):692–694

  • Home care services, home-based primary care for older adults with limited mobility, 36(4):550–556

  • Home health care, home health workers' interactions for heart failure, 36(2):369–375

  • Homebound persons, home-based primary care for older adults with limited mobility, 36(4):550–556

  • Homelessness, reflections in family medicine, 36(6):1020–1022

  • Hospitalists, ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163

  • Hospitalization

  •  COVID-19, health care costs following, 36(6):883–891

  •  COVID-19-related, delays in, 36(5):832–838

  •  hearing loss with, 36(3):439–448

  • Hospitals

  •  increasing primary care physicians in top leadership roles, 36(4):687–689

  •  primary care leadership in top ranked US hospitals, 36(4):682–684

  • Humanities, an exploration of professionalism in practice, 36(3):515–519

  • Hypertension, ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163

  • ICAN Discussion Aid, and patient burdens, 36(2):277–288

  • Immunization, adult MMR boosters and seroconversion, 36(1):142–144

  • Immunocompromised patients, COVID-19 mRNA vaccination trends, 36(6):927–932

  • Implementation science

  •  acceptance of social needs navigation, 36(2):229–239

  •  community health center social risk screening initiatives, 36(5):817–831

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  social screening within US health care settings, 36(4):626–649

  • Inclusiveness

  •  diversifying federal family medicine, 36(1):200–202

  •  physician racial diversity in federal sites, 36(1):188–189

  • Income, family physician early-career compensation, 36(5):851–863

  • Infectious diseases, use of patient-reporting system for predicting influenza, 36(5):766–776

  • Influenza, predicting, use of patient-reporting system for, 36(5):766–776

  • Informatics, providers and staff perceptions of AI, 36(2):221–228

  • Inhalers

  •  reducing carbon footprint when prescribing, 36(2):356–359

  •  what patients call, 36(4):650–661

  • Integrated behavioral health (IBH)

  •  adaptations during COVID-19, 36(6):1023–1028

  •  implementation and training in primary care, 36(6):1008–1019

  • Integrated delivery systems, IBH implementation and training in primary care, 36(6):1008–1019

  • Integrated health care systems, IBH adaptations during COVID-19, 36(6):1023–1028

  • Integrative medicine

  •  implementing whole person primary care, 36(4):542–549

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Interdisciplinary health team, demographics and engagement in interprofessional collaboration, 36(1):88–94

  • Interpersonal psychotherapy, detection and management of perinatal depression, 36(6):1071–1086

  • Intimate partner violence, and telemedicine usage, 36(5):755–765

  • Journal of the American Board of Family Medicine (JABFM)

  •  it’s time to retire the term “provider” from JABFM’s pages, 36(3):520–521

  •  peer reviewers for, 36(3):386–389

  • Judgment, role of practical wisdom in primary care, 36(4):531–536

  • Knowledge translation, role of practical wisdom in primary care, 36(4):531–536

  • Lactation, detection and management of perinatal depression, 36(6):1071–1086

  • Language concordance, quality of care for Latinx children with asthma, 36(4):616–625

  • Latinx

  •  delays in COVID-19-related hospitalization, 36(5):832–838

  •  quality of care for Latinx children with asthma, 36(4):616–625

  • Leadership

  •  an exploration of professionalism in practice, 36(3):515–519

  •  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057

  •  high-quality care requires worthwhile work, 36(1):193–199

  •  increasing primary care physicians in top leadership roles, 36(4):687–689

  •  in top ranked US hospitals, 36(4):682–684

  • Life expectancy, reduced, and peripheral neuropathy, 36(3):431–438

  • Lifestyle, goal-oriented prevention, 36(2):333–338

  • Linear regression

  •  demographics and engagement in interprofessional collaboration, 36(1):88–94

  •  weight loss management in primary care, 36(1):51–65

  • Logistic models

  •  low-value prostate cancer screening in primary care, 36(1):152–159

  •  telephonic follow-up and risk of COVID-19 death, 36(1):164–169

  • Logistic regression

  •  acceptance of social needs navigation, 36(2):229–239

  •  children's special health care needs during COVID-19, 36(5):731–738

  •  continuity of care and hospitalization, 36(2):303–312

  •  family physicians providing cesarean sections, 36(4):565–573

  •  high pain catastrophizing and opioid-related awareness, 36(2):267–276

  •  periodontitis among US adults with multimorbidity, 36(2):313–324

  •  urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  •  use of cancer survivorship guidelines, 36(5):789–802

  • Loneliness

  •  intimate partner violence and telemedicine usage, 36(5):755–765

  •  reflections in family medicine, 36(6):1020–1022

  •  social isolation and a resource referral platform, 36(5):803–816

  • Long-term adverse effects, severe harm due to screening colonoscopy, 36(3):493–500

  • Longitudinal studies

  •  COVID-19 and community health center care delivery, 36(6):916–926

  •  intimate partner violence and telemedicine usage, 36(5):755–765

  • Low back pain, acute, initial care for, 36(6):986–995

  • Lung cancer, screening

  •  among mammography patients, 36(4):557–564

  •  implementation, experiences with, 36(6):952–965

  • Lung injury, integrating a vaping assessment tool into the EHR, 36(3):405–413

  • Mammography

  •  patients, lung cancer screening among, 36(4):557–564

  •  screening, patient confidence in, 36(6):942–951

  •  women at high risk for breast cancer, 36(6):1029–1032

  • Maryland, integrating a vaping assessment tool into the EHR, 36(3):405–413

  • Mass screening, acceptance of social needs navigation, 36(2):229–239

  • Massachusetts, delays in COVID-19-related hospitalization, 36(5):832–838

  • Maternal health services

  •  attending deliveries and providing perinatal care, 36(4):685–686

  •  decline in family practitioners performing obstetric care, 36(4):690–691

  •  family physicians providing cesarean sections, 36(4):565–573

  • Measles-mumps-rubella (MMR) vaccine, adult MMR boosters and seroconversion, 36(1):142–144

  • Medicaid

  •  continuity of care and hospitalization, 36(2):303–312

  •  expansion, COVID-19, and practice ownership, 36(6):892–904

  • Medical assistants, high-quality care requires worthwhile work, 36(1):193–199

  • Medical decision-making, urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  • Medical education

  •  implementing competency-based ABFM board eligibility, 36(4):703–707

  •  physician perspectives on medical cannabis, 36(4):670–681

  • Medical ethics, clinical model of suffering, 36(2):344–355

  • Medical information, clinical decision support and medication prescribing, 36(5):777–788

  • Medical marijuana

  •  physician perspectives on, 36(4):670–681

  •  use for pain versus use for other reasons, 36(6):996–1007

  • Medically underserved areas

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Medically uninsured

  •  health insurance and chronic health conditions, 36(5):839–850

  •  telehealth and policy implications for equity, 36(5):746–754

  • Medicare

  •  health insurance and chronic health conditions, 36(5):839–850

  •  Medicare Advantage, growth amidst mounting scrutiny, 36(6):1062–1064

  •  physician continuity and cost of care, 36(6):976–985

  •  virtual Medicare Annual Wellness Visit intervention, 36(3):501–509

  • Medicare Advantage, growth amidst mounting scrutiny, 36(6):1062–1064

  • Medication-assisted treatment (MAT), utilization of MAT for opioid use disorder, 36(2):251–266

  • Melanoma, standards for dermoscopy education in primary care, 36(1):25–38

  • Men's health, low-value prostate cancer screening in primary care, 36(1):152–159

  • Mental health

  •  antidepressant tapering routine, 36(1):145–151

  •  burnout and commitment after COVID-19, 36(1):105–117

  •  children's special health care needs during COVID-19, 36(5):731–738

  •  delays in COVID-19-related hospitalization, 36(5):832–838

  •  IBH adaptations during COVID-19, 36(6):1023–1028

  •  ICAN Discussion Aid and patient burdens, 36(2):277–288

  •  impact of COVID-19 on care coordination patients, 36(4):662–669

  •  medical-legal partnership randomized clinical trials, 36(3):414–424

  •  parental ACEs and child weight, 36(1):39–50

  • Meta-analysis, denosumab versus bisphosphonates for reducing fractures, 36(1):175–185

  • Metabolic equivalent, tool to enhance functional status assessment, 36(1):4–14

  • Metered dose inhalers, carbon footprint, 36(2):356–359

  • Michigan, hearing loss with hospitalization, 36(3):439–448

  • Minnesota, parental ACEs and child weight, 36(1):39–50

  • Minority health

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Monetary incentives, and COVID-19 vaccination, 36(1):170–174

  • Morbidity, patient's characteristics and management of symptom diagnoses, 36(3):477–492

  • Motivation, high pain catastrophizing and opioid-related awareness, 36(2):267–276

  • Multidisciplinary care team, home-based primary care for older adults with limited mobility, 36(4):550–556

  • Multimorbidity

  •  health insurance and chronic health conditions, 36(5):839–850

  •  periodontitis among US adults with, 36(2):313–324

  • Musculoskeletal diseases, outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  • Musculoskeletal pain, initial care for acute low back pain, 36(6):986–995

  • Music therapy, virtual, for substance use disorders, 36(6):1043–1049

  • Narcotics, utilization of MAT for opioid use disorder, 36(2):251–266

  • National Ambulatory Medical Care Survey (NAMCS)

  •  low-value prostate cancer screening in primary care, 36(1):152–159

  •  obesity and the patient-physician relationship, 36(2):325–332

  • Natural language processing (NLP), capture of social needs through, 36(3):513–514

  • New York

  •  home health workers' interactions for heart failure, 36(2):369–375

  •  integrating harm reduction into medical care, 36(3):449–461

  • Newborns

  •  attending deliveries and providing perinatal care, 36(4):685–686

  •  decline in family practitioners performing obstetric care, 36(4):690–691

  •  landscape of pregnancy care in community health centers, 36(4):574–582

  • Nicotine, integrating a vaping assessment tool into the EHR, 36(3):405–413

  • Norflurane, reducing carbon footprint when prescribing inhalers, 36(2):356–359

  • Nurses, standing orders for buprenorphine follow-up care, 36(5):723–730

  • Nutrition surveys

  •  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476

  •  periodontitis among US adults with multimorbidity, 36(2):313–324

  • Obesity

  •  models for delivering weight management, 36(4):603–615

  •  and patient-physician relationship, 36(2):325–332

  • Obstetrics

  •  family physicians providing cesarean sections, 36(4):565–573

  •  landscape of pregnancy care in community health centers, 36(4):574–582

  • Occupational burnout

  •  after COVID-19, 36(1):105–117

  •  impact of COVID-19 on family physicians, 36(6):905–915

  • Ohio, financial incentives and COVID-19 vaccination, 36(1):170–174

  • Opiate substitution treatment, integrating harm reduction into medical care, 36(3):449–461

  • Opioid-related disorders

  •  end of the “X-waiver” program, 36(5):867–872

  •  integrating harm reduction into medical care, 36(3):449–461

  •  nurse standing orders for buprenorphine follow-up care, 36(5):723–730

  •  utilization of MAT for, 36(2):251–266

  • Opioids

  •  end of the “X-waiver” program, 36(5):867–872

  •  high pain catastrophizing and opioid-related awareness, 36(2):267–276

  •  nurse standing orders for buprenorphine follow-up care, 36(5):723–730

  •  urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  • Oregon

  •  acceptance of social needs navigation, 36(2):229–239

  •  data challenges for rural colorectal cancer screening, 36(1):118–129

  •  experiences with lung cancer screening implementation, 36(6):952–965

  • Organizational innovation

  •  implementing whole person primary care, 36(4):542–549

  •  models for delivering weight management, 36(4):603–615

  • Orthopedics, outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  • Osteoporosis, denosumab versus bisphosphonates for reducing fractures, 36(1):175–185

  • Osteoporotic fractures, reducing, denosumab versus bisphosphonates, 36(1):175–185

  • Outcomes assessment

  •  non-adherence behaviors and diabetes outcomes, 36(1):15–24

  •  quality of care for Latinx children with asthma, 36(4):616–625

  •  what patients call their inhalers, 36(4):650–661

  • Outcomes research, home health workers' interactions for heart failure, 36(2):369–375

  • Outpatients, virtual music therapy for substance use disorders, 36(6):1043–1049

  • Pain, high pain catastrophizing and opioid-related awareness, 36(2):267–276

  • Palliative care, clinical model of suffering, 36(2):344–355

  • Pandemics

  •  ACGME's new family and medical leave policy, 36(1):190–192

  •  adherence to diabetes medications during COVID-19, 36(2):289–302

  •  burnout and commitment after COVID-19, 36(1):105–117

  •  children's special health care needs during COVID-19, 36(5):731–738

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  COVID-19 and community health center care delivery, 36(6):916–926

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  fraud, access, and future of telemedicine, 36(5):864–866

  •  health care costs following COVID-19 hospitalization, 36(6):883–891

  •  IBH adaptations during COVID-19, 36(6):1023–1028

  •  impact of COVID-19 on care coordination patients, 36(4):662–669

  •  impact of COVID-19 on family physicians, 36(6):905–915

  •  intimate partner violence and telemedicine usage, 36(5):755–765

  •  telehealth and policy implications for equity, 36(5):746–754

  • Parenting, parental ACEs and child weight, 36(1):39–50

  • Patient adherence, lung cancer screening among mammography patients, 36(4):557–564

  • Patient care team

  •  an exploration of professionalism in practice, 36(3):515–519

  •  continuity, payment, and terms in Canadian health, 36(1):130–141

  •  demographics and engagement in interprofessional collaboration, 36(1):88–94

  •  IBH implementation and training in primary care, 36(6):1008–1019

  •  nurse standing orders for buprenorphine follow-up care, 36(5):723–730

  • Patient-centered care

  •  clinical model of suffering, 36(2):344–355

  •  community health center social risk screening initiatives, 36(5):817–831

  •  goal-oriented prevention, 36(2):333–338

  •  ICAN Discussion Aid and patient burdens, 36(2):277–288

  • Patient-centered medical home, pharmacist e-consult in primary care, 36(3):425–430

  • Patient confidence, in screening mammography, 36(6):942–951

  • Patient education, high pain catastrophizing and opioid-related awareness, 36(2):267–276

  • Patient harm, severe harm due to screening colonoscopy, 36(3):493–500

  • Patient-oriented research, non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  • Patient readmission

  •  appointment cancellations and hospital utilization, 36(2):339–343

  •  hearing loss with hospitalization, 36(3):439–448

  • Pediatrics, childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042

  • Pennsylvania, physician perspectives on medical cannabis, 36(4):670–681

  • Periodontitis, among US adults with multimorbidity, 36(2):313–324

  • Peripheral nervous system, diseases, and reduced life expectancy, 36(3):431–438

  • Peripheral neuropathies, and reduced life expectancy, 36(3):431–438

  • Person-centered care, implementing whole person primary care, 36(4):542–549

  • Personal satisfaction, intimate partner violence and telemedicine usage, 36(5):755–765

  • Personnel relations, attrition in a multispecialty ambulatory practice network, 36(6):1050–1057

  • Pharmacists

  •  e-consult in primary care, 36(3):425–430

  •  increasing treatment rates for hepatitis C, 36(4):591–602

  • Pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067

  • Physician-patient relations

  •  and obesity, 36(2):325–332

  •  reflections in family medicine, 36(6):1020–1022

  •  urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  •  what patients call their inhalers, 36(4):650–661

  • Physicians

  •  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057

  •  end of the “X-waiver” program, 36(5):867–872

  •  increasing treatment rates for hepatitis C, 36(4):591–602

  •  leadership in top ranked US hospitals, 36(4):682–684

  •  low-value prostate cancer screening in primary care, 36(1):152–159

  •  physician continuity and cost of care, 36(6):976–985

  •  utilization of MAT for opioid use disorder, 36(2):251–266

  • Physician's role, practical wisdom in primary care, 36(4):531–536

  • Policy

  •  ACGME's new family and medical leave policy, 36(1):190–192

  •  end of the “X-waiver” program, 36(5):867–872

  • Population health, community health center social risk screening initiatives, 36(5):817–831

  • Population health management, data challenges for rural colorectal cancer screening, 36(1):118–129

  • Postmenopause, denosumab versus bisphosphonates for reducing fractures, 36(1):175–185

  • Postpartum depression, detection and management of, 36(6):1071–1086

  • Postpartum period

  •  attending deliveries and providing perinatal care, 36(4):685–686

  •  decline in family practitioners performing obstetric care, 36(4):690–691

  •  landscape of pregnancy care in community health centers, 36(4):574–582

  • Practice-based research

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  IBH implementation and training in primary care, 36(6):1008–1019

  • Practice guidelines, clinical decision support and medication prescribing, 36(5):777–788

  • Practice management, practice type and scope of care, 36(1):79–87

  • Pregnancy

  •  attending deliveries and providing perinatal care, 36(4):685–686

  •  decline in family practitioners performing obstetric care, 36(4):690–691

  •  detection and management of perinatal depression, 36(6):1071–1086

  •  pregnancy care in community health centers, 36(4):574–582

  • Prenatal care, in community health centers, 36(4):574–582

  • Preparticipation physical examinations, and failure to participate in sports, 36(6):1033–1037

  • Prescription drugs, pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067

  • Prescriptions

  •  end of the “X-waiver” program, 36(5):867–872

  •  Medicare Advantage: growth amidst mounting scrutiny, 36(6):1062–1064

  • Preventive care

  •  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476

  •  goal-oriented prevention, 36(2):333–338

  • Preventive health services, virtual Medicare Annual Wellness Visit intervention, 36(3):501–509

  • Preventive medicine

  •  lung cancer screening among mammography patients, 36(4):557–564

  •  severe harm due to screening colonoscopy, 36(3):493–500

  • Primary care

  •  adherence to diabetes medications during COVID-19, 36(2):289–302

  •  antidepressant tapering routine, 36(1):145–151

  •  appointment cancellations and hospital utilization, 36(2):339–343

  •  burnout and commitment after COVID-19, 36(1):105–117

  •  cannabis use for pain versus use for other reasons, 36(6):996–1007

  •  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476

  •  clinical decision support and medication prescribing, 36(5):777–788

  •  clinical model of suffering, 36(2):344–355

  •  continuity, payment, and terms in Canadian health, 36(1):130–141

  •  continuity of care and hospitalization, 36(2):303–312

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  COVID-19 and community health center care delivery, 36(6):916–926

  •  demographics and engagement in interprofessional collaboration, 36(1):88–94

  •  experiences with lung cancer screening implementation, 36(6):952–965

  •  food insecurity screening in safety-net clinics, 36(2):240–250

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  goal-oriented prevention, 36(2):333–338

  •  guidelines for germline testing of colorectal cancer, 36(2):360–365

  •  high-quality care requires worthwhile work, 36(1):193–199

  •  home-based primary care for older adults with limited mobility, 36(4):550–556

  •  IBH adaptations during COVID-19, 36(6):1023–1028

  •  IBH implementation and training in, 36(6):1008–1019

  •  impact of COVID-19 on care coordination patients, 36(4):662–669

  •  impact of COVID-19 on family physicians, 36(6):905–915

  •  implementing whole person primary care, 36(4):542–549

  •  increasing treatment rates for hepatitis C, 36(4):591–602

  •  initial care for acute low back pain, 36(6):986–995

  •  integrating harm reduction into medical care, 36(3):449–461

  •  low-value prostate cancer screening in, 36(1):152–159

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  •  obesity and patient-physician relationship, 36(2):325–332

  •  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  •  peripheral neuropathy and reduced life expectancy, 36(3):431–438

  •  pharmacist e-consult in, 36(3):425–430

  •  physician continuity and cost of care, 36(6):976–985

  •  practice type and scope of care, 36(1):79–87

  •  quality of care for Latinx children with asthma, 36(4):616–625

  •  role of practical wisdom in, 36(4):531–536

  •  standards for dermoscopy education in, 36(1):25–38

  •  telehealth and policy implications for equity, 36(5):746–754

  •  telephonic follow-up and risk of COVID-19 death, 36(1):164–169

  •  use of cancer survivorship guidelines, 36(5):789–802

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  •  weight loss management in, 36(1):51–65

  • Primary care physicians

  •  leadership in top ranked US hospitals, 36(4):682–684

  •  top leadership roles, increasing, 36(4):687–689

  • Professionalism, an exploration of professionalism in practice, 36(3):515–519

  • Prognosis, peripheral neuropathy and reduced life expectancy, 36(3):431–438

  • Program evaluation, nurse standing orders for buprenorphine follow-up care, 36(5):723–730

  • Propensity score, health care costs following COVID-19 hospitalization, 36(6):883–891

  • Prospective studies

  •  hearing loss with hospitalization, 36(3):439–448

  •  initial care for acute low back pain, 36(6):986–995

  •  patient confidence in screening mammography, 36(6):942–951

  •  use of patient-reporting system for predicting influenza, 36(5):766–776

  • Prostate cancer, low-value prostate cancer screening in primary care, 36(1):152–159

  • Prostate-specific antigen, low-value prostate cancer screening in primary care, 36(1):152–159

  • Psychiatry

  •  antidepressant tapering routine, 36(1):145–151

  •  detection and management of perinatal depression, 36(6):1071–1086

  • Psychological burnout

  •  ACGME's new family and medical leave policy, 36(1):190–192

  •  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057

  •  impact of COVID-19 on family physicians, 36(6):905–915

  • Psychosocial intervention, detection and management of perinatal depression, 36(6):1071–1086

  • Public health

  •  adult MMR boosters and seroconversion, 36(1):142–144

  •  FDA initiative for diversity in clinical trials, 36(2):366–368

  •  food insecurity screening in safety-net clinics, 36(2):240–250

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  •  reflections in family medicine, 36(6):1020–1022

  • Qualitative research

  •  AI applications in primary care, 36(2):210–220

  •  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057

  •  burnout and commitment after COVID-19, 36(1):105–117

  •  community health center social risk screening initiatives, 36(5):817–831

  •  core values of family medicine and abortion provision, 36(4):583–590

  •  delays in COVID-19-related hospitalization, 36(5):832–838

  •  financial incentives and COVID-19 vaccination, 36(1):170–174

  •  food insecurity screening in safety-net clinics, 36(2):240–250

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  IBH implementation and training in primary care, 36(6):1008–1019

  •  impact of COVID-19 on care coordination patients, 36(4):662–669

  •  integrating harm reduction into medical care, 36(3):449–461

  •  models for delivering weight management, 36(4):603–615

  •  non-prescription antibiotic use among Hispanic patients, 36(3):390–404

  •  physician perspectives on medical cannabis, 36(4):670–681

  •  providers and staff perceptions of AI, 36(2):221–228

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Quality improvement

  •  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476

  •  clinical decision support and medication prescribing, 36(5):777–788

  •  deployment of digital advance care planning platform, 36(6):966–975

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  increasing treatment rates for hepatitis C, 36(4):591–602

  •  physician perspectives on medical cannabis, 36(4):670–681

  • Quality of life

  •  clinical model of suffering, 36(2):344–355

  •  medical-legal partnership randomized clinical trials, 36(3):414–424

  • Radiography, outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  • Referral and consultation

  •  experiences with lung cancer screening implementation, 36(6):952–965

  •  medical-legal partnership randomized clinical trials, 36(3):414–424

  •  pharmacist e-consult in primary care, 36(3):425–430

  •  social isolation and a resource referral platform, 36(5):803–816

  •  women at high risk for breast cancer, 36(6):1029–1032

  • Remote consultation

  •  pharmacist e-consult in primary care, 36(3):425–430

  •  telephonic follow-up and risk of COVID-19 death, 36(1):164–169

  • Residency, IBH implementation and training in primary care, 36(6):1008–1019

  • Respiratory tract diseases, patient-reporting system for predicting influenza, 36(5):766–776

  • Retrospective studies

  •  appointment cancellations and hospital utilization, 36(2):339–343

  •  COVID-19 mRNA vaccination trends, 36(6):927–932

  •  deployment of digital advance care planning platform, 36(6):966–975

  •  health insurance and chronic health conditions, 36(5):839–850

  •  hearing loss with hospitalization, 36(3):439–448

  •  landscape of pregnancy care in community health centers, 36(4):574–582

  •  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  •  patient's characteristics and management of symptom diagnoses, 36(3):477–492

  •  urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  • Rickets, infant and maternal vitamin D supplementation, 36(1):95–104

  • Risk assessment, guidelines for germline testing of colorectal cancer, 36(2):360–365

  • Rural health

  •  data challenges for colorectal cancer screening, 36(1):118–129

  •  multi-component intervention for colorectal cancer screening, 36(6):933–941

  •  practice type and scope of care, 36(1):79–87

  • Rural population

  •  family physicians providing cesarean sections, 36(4):565–573

  •  telehealth and policy implications for equity, 36(5):746–754

  • Safety-net clinics

  •  food insecurity screening in, 36(2):240–250

  •  FQHC telemedicine care redesign, 36(5):712–722

  • SARS-CoV-2, telephonic follow-up and risk of COVID-19 death, 36(1):164–169

  • Scope of care, practice type and, 36(1):79–87

  • Scoping review, implementation of social screening within US health care settings, 36(4):626–649

  • Screening

  •  community health center social risk screening initiatives, 36(5):817–831

  •  data challenges for rural colorectal cancer screening, 36(1):118–129

  •  experiences with lung cancer screening implementation, 36(6):952–965

  •  implementation of social screening within US health care settings, 36(4):626–649

  •  lung cancer screening among mammography patients, 36(4):557–564

  •  multi-component intervention and colorectal cancer screening, 36(6):933–941

  •  patient and patient caregiver perspectives on social screening, 36(1):66–78

  •  patient confidence in screening mammography, 36(6):942–951

  •  preparticipation sports physicals, 36(6):1033–1037

  •  reflections in family medicine, 36(6):1020–1022

  •  social isolation and a resource referral platform, 36(5):803–816

  •  women at high risk for breast cancer, 36(6):1029–1032

  • Selective serotonin reuptake inhibitors, detection and management of perinatal depression, 36(6):1071–1086

  • Seroconversion, adult MMR boosters and seroconversion, 36(1):142–144

  • Shared decision-making, ICAN Discussion Aid and patient burdens, 36(2):277–288

  • Sick leave, ACGME's new family and medical leave policy, 36(1):190–192

  • Signs and symptoms, patient's characteristics and management of symptom diagnoses, 36(3):477–492

  • Skin cancer, standards for dermoscopy education in primary care, 36(1):25–38

  • Small intestine, ACE inhibitor-induced angioedema of, 36(1):160–163

  • Social care, patient and patient caregiver perspectives on social screening, 36(1):66–78

  • Social determinants of health

  •  acceptance of social needs navigation, 36(2):229–239

  •  capture of social needs through NLP, 36(3):513–514

  •  community health center social risk screening initiatives, 36(5):817–831

  •  determining patients' social needs in EHRs, 36(3):510–512

  •  FDA initiative for diversity in clinical trials, 36(2):366–368

  •  food insecurity screening in safety-net clinics, 36(2):240–250

  •  implementation of social screening within US health care settings, 36(4):626–649

  •  medical-legal partnership randomized clinical trials, 36(3):414–424

  •  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  •  patient and patient caregiver perspectives on social screening, 36(1):66–78

  •  reflections in family medicine, 36(6):1020–1022

  •  social isolation and a resource referral platform, 36(5):803–816

  • Social isolation, reflections in family medicine, 36(6):1020–1022

  • Social problems, reflections in family medicine, 36(6):1020–1022

  • Social risk factors

  •  implementation of social screening within US health care settings, 36(4):626–649

  •  social isolation and a resource referral platform, 36(5):803–816

  • Socioeconomic factors, patient and patient caregiver perspectives on social screening, 36(1):66–78

  • Solo practice, race and ethnicity differences in solo practices, 36(2):380–381

  • Southwestern United States, extra-articular coccidioidomycosis in the knee, 36(2):376–379

  • Special communications

  •  An Exploration of Professionalism in Everyday Practice, 36(3):515–519

  •  A Comprehensive Clinical Model of Suffering, 36(2):344–355

  •  Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”--Reducing Carbon Footprint When Prescribing Inhalers, 36(2):356–359

  • Special health care needs, children's, during COVID-19, 36(5):731–738

  • Specialty boards, implementing competency-based ABFM board eligibility, 36(4):703–707

  • Sports medicine

  •  extra-articular coccidioidomycosis in the knee, 36(2):376–379

  •  failure to participate in sports, 36(6):1033–1037

  • Standards, role of practical wisdom in primary care, 36(4):531–536

  • Standing orders, nurse, for buprenorphine follow-up care, 36(5):723–730

  • Structural equation modeling, parental ACEs and child weight, 36(1):39–50

  • Students

  •  failure to participate in sports, 36(6):1033–1037

  •  use of patient-reporting system for predicting influenza, 36(5):766–776

  • Substance-abuse testing, urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  • Substance-related disorders

  •  an exploration of professionalism in practice, 36(3):515–519

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Substance use disorders, nurse standing orders for buprenorphine follow-up care, 36(5):723–730

  • Suffering, clinical model of, 36(2):344–355

  • Surveys and questionnaires

  •  advanced practice providers in family medicine departments, 36(6):1058–1061

  •  comparing cannabis use for pain to use for other reasons, 36(6):996–1007

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  detection and management of perinatal depression, 36(6):1071–1086

  •  determining patients' social needs in EHRs, 36(3):510–512

  •  financial incentives and COVID-19 vaccination, 36(1):170–174

  •  impact of COVID-19 on family physicians, 36(6):905–915

  •  patient confidence in screening mammography, 36(6):942–951

  •  tool to enhance functional status assessment, 36(1):4–14

  • Survivorship, use of cancer survivorship guidelines, 36(5):789–802

  • Sustained virologic response, increasing treatment rates for hepatitis C, 36(4):591–602

  • Systematic review

  •  implementation of social screening within US health care settings, 36(4):626–649

  •  patient and patient caregiver perspectives on social screening, 36(1):66–78

  •  severe harm due to screening colonoscopy, 36(3):493–500

  • Systems change, increasing primary care physicians in top leadership roles, 36(4):687–689

  • Telemedicine

  •  acceptance of social needs navigation, 36(2):229–239

  •  FQHC telemedicine care redesign, 36(5):712–722

  •  fraud, access, and future of telemedicine, 36(5):864–866

  •  intimate partner violence and telemedicine usage, 36(5):755–765

  •  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745

  •  telehealth and policy implications for equity, 36(5):746–754

  •  use of patient-reporting system for predicting influenza, 36(5):766–776

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Telephone, follow-up, and risk of COVID-19 death, 36(1):164–169

  • Tennessee, tool to enhance functional status assessment, 36(1):4–14

  • Training, implementing whole person primary care, 36(4):542–549

  • Treatment adherence, non-adherence behaviors and diabetes outcomes, 36(1):15–24

  • Triage, use of patient-reporting system for predicting influenza, 36(5):766–776

  • Uncertainty, role of practical wisdom in primary care, 36(4):531–536

  • Urgent care, practice type and scope of care, 36(1):79–87

  • Urine collection, urine drug testing in patients prescribed opioid therapy, 36(4):537–541

  • U.S. Department of Health and Human Services, fraud, access, and future of telemedicine, 36(5):864–866

  • U.S. Department of Veterans Affairs

  •  diversifying federal family medicine, 36(1):200–202

  •  physician racial diversity in federal sites, 36(1):188–189

  • Vaccination

  •  adult MMR boosters and seroconversion, 36(1):142–144

  •  COVID-19 mRNA vaccination trends, 36(6):927–932

  •  health care costs following COVID-19 hospitalization, 36(6):883–891

  • Vaccination hesitancy, financial incentives and COVID-19 vaccination, 36(1):170–174

  • Values, core, of family medicine, and abortion provision, 36(4):583–590

  • Vaping, assessment tool, integrating into the EHR, 36(3):405–413

  • Veterans, adherence to diabetes medications during COVID-19, 36(2):289–302

  • Veterans Health Administration, pharmacist e-consult in primary care, 36(3):425–430

  • Virginia

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  physician continuity and cost of care, 36(6):976–985

  • Virtual systems, Medicare Annual Wellness Visit intervention, 36(3):501–509

  • Vitamin D, infant and maternal vitamin D supplementation, 36(1):95–104

  • Vulnerable populations

  •  integrating a vaping assessment tool into the EHR, 36(3):405–413

  •  landscape of pregnancy care in community health centers, 36(4):574–582

  •  virtual music therapy for substance use disorders, 36(6):1043–1049

  • Washington, cannabis use for pain versus use for other reasons, 36(6):996–1007

  • Weight loss

  •  models for delivering weight management, 36(4):603–615

  •  weight loss management in primary care, 36(1):51–65

  • Workflow, experiences with lung cancer screening implementation, 36(6):952–965

  • Workforce

  •  advanced practice providers in family medicine departments, 36(6):1058–1061

  •  attending deliveries and providing perinatal care, 36(4):685–686

  •  burnout and commitment after COVID-19, 36(1):105–117

  •  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904

  •  decline in family practitioners performing obstetric care, 36(4):690–691

  •  demographics and engagement in interprofessional collaboration, 36(1):88–94

  •  diversifying federal family medicine, 36(1):200–202

  •  family physician early-career compensation, 36(5):851–863

  •  family physicians providing cesarean sections, 36(4):565–573

  •  high-quality care requires worthwhile work, 36(1):193–199

  •  impact of COVID-19 on family physicians, 36(6):905–915

  •  implementing whole person primary care, 36(4):542–549

  •  pharmacist e-consult in primary care, 36(3):425–430

  •  physician racial diversity in federal sites, 36(1):188–189

  •  practice type and scope of care, 36(1):79–87

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 36 (6)
The Journal of the American Board of Family Medicine
Vol. 36, Issue 6
November-December 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Subject Index to Volume 36, 2023
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Subject Index to Volume 36, 2023
The Journal of the American Board of Family Medicine Nov 2023, 36 (6) 1105-1115;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Subject Index to Volume 36, 2023
The Journal of the American Board of Family Medicine Nov 2023, 36 (6) 1105-1115;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Subject Index to Volume 37, 2024
  • Author Index to Volume 37, 2024
  • Author Index to Volume 36, 2023
Show more Indices

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire